APPROACH Study
Mosaic Design
APPROACH, a preventive vaccine study, seeks to address more than one clade
by Jeannie Wraight
Over the past thirty-plus years, strategies such as Treatment as...
Women & PrEP
LifeGuide
It's a Man's World
Research on women & PrEP needs to keep pace
by Jeannie Wraight
Whereas HIV cure and HIV prevention are two very different...
Novel Cure Research Supported by amfAR
Deciphering the Puzzle
A new round of amfAR's Countdown to a Cure initiative grants support novel cure research
by Jeannie Wraight
amfAR has awarded a new round...
HIV reportedly “cured” in patient in London
For only the second time in the history of the AIDS pandemic, a patient with HIV in London seems to have been freed of...
Counting Cures
Destination: Cure by Jeannie Wraight
Counting Cures
Before we start tallying “cures,” let’s strive to define what we mean by “cured?”
Several months ago a media frenzy...
Talking “Cure”
Nobel Prize Laureate and world renowned HIV researcher Françoise Barré-Sinoussi recently made the statement that she does not believe an HIV cure is possible....
Cure Research: CROI 2018
Fast Look
Cure research highlights from CROI 2018
by Jeannie Wraight
The Conference on Retroviruses and Opportunistic Infections (CROI) provides an annual snapshot of the year’s most...
AR-12: One Drug Candidate, Many Possibilities
One Drug, Many Possibilities
A new agent may assist in the fight against HIV and other viruses
by Jeannie Wraight
Every once in a while I come...
4 CROI Briefs
Another year of the Conference on Retroviruses and Opportunistic Infections (CROI 2016) has come to pass. Here are a few less publicized but important...
Broad Spectrum Antivirals: Part II
Beyond One Bug, One Drug
Broad spectrum antivirals shift the drug model paradigm, part II
by Jeannie Wraight
In the October issue of A&U, Destination: Cure explored...
LATEST POSTS
Ron B: Cover Story
“You had me at Angels in America,” I tell Ron B. when I see her at the Manhattan Neighborhood Network studios, in New York...
